- Drug already available in marketplace.
- Oral pill given daily.
- Studied in patients with RRMS.
- Estrogen-like hormone that may have both neuroprotective and anti-inflammatory properties.
- Studies are based on the fact that individuals with autoimmune disease often experience reduced disease activity during pregnancy; estrogen is thought to suppress the immune system during pregnancy so the fetus is not identified as a foreign body, thereby avoiding an attack from the immune system.
- Small pilot study wih 10 non-pregnant women showed an 80-percent reduction in enhancing lesions; also showed cognitive improvements.
- Seven universities in the United States are conducting a larger trial, enrolling 150 participants to receive daily Copaxone injections along with a daily estriol pill or a placebo.